InMed Pharmaceuticals Inc. (INM)
USD 3.09
(-0.16%)
USD 3.09
(-0.16%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 644.86 Million USD | 145.76% |
| 2023 | 391.7 Thousand USD | -50.65% |
| 2022 | 793.77 Thousand USD | 194.24% |
| 2021 | 269.77 Thousand USD | -14.7% |
| 2020 | 316.27 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | -100.0% |
| 2010 | 97.06 Thousand CAD | 68.65% |
| 2009 | 57.55 Thousand CAD | 49.63% |
| 2008 | 38.46 Thousand CAD | 0.0% |
| 2007 | - CAD | -100.0% |
| 2006 | 114.85 Thousand CAD | 130.68% |
| 2005 | 49.79 Thousand CAD | -63.45% |
| 2004 | 136.21 Thousand CAD | 107.91% |
| 2003 | 65.51 Thousand CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.16 Million USD | 298.29% |
| 2024 Q4 | 644.86 Million USD | -10.1% |
| 2024 Q3 | 1.07 Million USD | -8.24% |
| 2024 Q1 | 292.99 Thousand USD | -25.2% |
| 2023 Q2 | 598.2 Thousand USD | -14.36% |
| 2023 Q4 | 391.7 Thousand USD | -21.09% |
| 2023 FY | 391.7 Thousand USD | -50.65% |
| 2023 Q3 | 496.36 Thousand USD | -17.02% |
| 2023 Q1 | 698.5 Thousand USD | -12.0% |
| 2022 Q3 | 922.77 Thousand USD | -12.04% |
| 2022 Q4 | 793.77 Thousand USD | -13.98% |
| 2022 FY | 793.77 Thousand USD | 194.24% |
| 2022 Q1 | 260.82 Thousand USD | -3.32% |
| 2022 Q2 | 1.04 Million USD | 302.22% |
| 2021 Q4 | 269.77 Thousand USD | -8.57% |
| 2021 Q1 | 307 Thousand CAD | -2.93% |
| 2021 Q3 | 295.05 Thousand USD | -6.42% |
| 2021 FY | 269.77 Thousand USD | -14.7% |
| 2021 Q2 | 315.3 Thousand USD | 2.7% |
| 2020 Q1 | 380.66 Thousand CAD | 0.0% |
| 2020 Q4 | 316.27 Thousand CAD | -1.73% |
| 2020 Q3 | 321.84 Thousand CAD | -12.49% |
| 2020 Q2 | 367.77 Thousand CAD | -3.39% |
| 2020 FY | 316.27 Thousand CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | -100.0% |
| 2015 Q2 | 217.2 Thousand CAD | 109.01% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | 103.92 Thousand CAD | 0.0% |
| 2015 Q3 | 118.31 Thousand CAD | -45.53% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q1 | 103.04 Thousand CAD | 6.16% |
| 2011 FY | - CAD | -100.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | -100.0% |
| 2011 Q2 | 110.3 Thousand CAD | 7.04% |
| 2010 Q2 | 159.74 Thousand CAD | 36.15% |
| 2010 Q3 | 211.07 Thousand CAD | 32.13% |
| 2010 Q4 | 97.06 Thousand CAD | -54.01% |
| 2010 FY | 97.06 Thousand CAD | 68.65% |
| 2010 Q1 | 117.33 Thousand CAD | 103.86% |
| 2009 Q4 | 57.55 Thousand CAD | 38.16% |
| 2009 FY | 57.55 Thousand CAD | 49.63% |
| 2009 Q3 | 41.65 Thousand CAD | 124.32% |
| 2009 Q2 | 18.57 Thousand CAD | -43.13% |
| 2009 Q1 | 32.65 Thousand CAD | -15.09% |
| 2008 Q2 | 16.26 Thousand CAD | 0.0% |
| 2008 Q3 | 34.91 Thousand CAD | 114.58% |
| 2008 Q4 | 38.46 Thousand CAD | 10.18% |
| 2008 FY | 38.46 Thousand CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 Q2 | 101.13 Thousand CAD | 63.99% |
| 2007 Q1 | 61.67 Thousand CAD | -46.31% |
| 2007 FY | - CAD | -100.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | -100.0% |
| 2006 Q3 | 47.82 Thousand CAD | -79.42% |
| 2006 FY | 114.85 Thousand CAD | 130.68% |
| 2006 Q2 | 232.45 Thousand CAD | 792.92% |
| 2006 Q1 | 26.03 Thousand CAD | -47.71% |
| 2006 Q4 | 114.85 Thousand CAD | 140.14% |
| 2005 Q2 | 1.91 Million CAD | 1108.24% |
| 2005 Q3 | 865.56 Thousand CAD | -54.75% |
| 2005 Q4 | 49.79 Thousand CAD | -94.25% |
| 2005 FY | 49.79 Thousand CAD | -63.45% |
| 2005 Q1 | 158.3 Thousand CAD | 16.22% |
| 2004 Q2 | 69.43 Thousand CAD | -0.39% |
| 2004 Q4 | 136.21 Thousand CAD | 103.15% |
| 2004 FY | 136.21 Thousand CAD | 107.91% |
| 2004 Q1 | 69.7 Thousand CAD | 6.4% |
| 2004 Q3 | 67.04 Thousand CAD | -3.43% |
| 2003 FY | 65.51 Thousand CAD | 0.0% |
| 2003 Q4 | 65.51 Thousand CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -454030.282% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -8321.465% |
| XOMA Corporation | 124.45 Million USD | -418.172% |
| Mesoblast Limited | 118.92 Million USD | -442.254% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -181.366% |
| Aptorum Group Limited | 3.36 Million USD | -19078.729% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -49534.934% |
| HilleVax, Inc. | 51.19 Million USD | -1159.674% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -2475.134% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2987.808% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1962.38% |
| Dyadic International, Inc. | 136.92 Thousand USD | -470848.448% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -408042.405% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -22353.517% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -11721.54% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -301238.785% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -11691.278% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -181.07% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -5090.478% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1492.023% |
| Opthea Limited | 200.62 Million USD | -221.422% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1145.514% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -11841.944% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -6471.538% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -10360.097% |
| NextCure, Inc. | 6.6 Million USD | -9663.285% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -103575.545% |
| Ovid Therapeutics Inc. | 46 Million USD | -1301.828% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2936.231% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2034.184% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -938.848% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1612.061% |
| Apollomics, Inc. | 4.66 Million USD | -13735.336% |
| PureTech Health plc | 25.51 Million USD | -2427.693% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -202687.736% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -4869.675% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -661.586% |
| ChromaDex Corporation | 3.27 Million USD | -19578.517% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -518.979% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1592.381% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -515.476% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -522.841% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -536.062% |
| Fortress Biotech, Inc. | 88.59 Million USD | -627.904% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -920.889% |
| Celcuity Inc. | 37.44 Million USD | -1622.107% |
| ContextLogic Inc. | 6 Million USD | -10647.75% |
| GH Research PLC | 343 Thousand USD | -187907.289% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -9731.758% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1742778.378% |
| ImmuCell Corporation | 11.96 Million USD | -5287.657% |
| Amarin Corporation plc | 8.73 Million USD | -7280.852% |
| TG Therapeutics, Inc. | 110.79 Million USD | -482.034% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1006.476% |
| Acelyrin, Inc. | 1.19 Million USD | -53908.794% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -2181.981% |
| Novavax, Inc. | 280.63 Million USD | -129.788% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -363.832% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 88.875% |
| AnaptysBio, Inc. | 17.81 Million USD | -3519.99% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -11848.583% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -4753.718% |
| AbCellera Biologics Inc. | 77.38 Million USD | -733.374% |
| CorMedix Inc. | 667.63 Thousand USD | -96489.888% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -5786.49% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 76.142% |
| Aptose Biosciences Inc. | 1 Million USD | -63760.286% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -7449819.131% |
| Soligenix, Inc. | 3.49 Million USD | -18353.391% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1238.7% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -459.92% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -143021.728% |
| Kura Oncology, Inc. | 17.2 Million USD | -3649.215% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -9237.75% |
| Ardelyx, Inc. | 55.98 Million USD | -1051.915% |
| Ainos, Inc. | 5.96 Million USD | -10713.431% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -597.657% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -29893.721% |
| Prothena Corporation plc | 11.83 Million USD | -5348.796% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -4514.749% |
| Autolus Therapeutics plc | 52.96 Million USD | -1117.484% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -2455.439% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1441.154% |
| Celularity Inc. | 65.41 Million USD | -885.776% |
| Rallybio Corporation | 392 Thousand USD | -164406.378% |
| GRI Bio, Inc. | 14 Thousand USD | -4606078.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -90.63% |
| INmune Bio, Inc. | 10.43 Million USD | -6078.643% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -259.0% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -10816.854% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -789401.714% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -77891.133% |
| Humacyte, Inc. | 58.1 Million USD | -1009.808% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1014.295% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -34.112% |
| Immunocore Holdings plc | 84.03 Million USD | -667.404% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -34701.133% |
| Verastem, Inc. | 41.55 Million USD | -1451.76% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -5570.638% |
| Histogen Inc. | 4.62 Million USD | -13852.077% |
| Surrozen, Inc. | 3.37 Million USD | -18984.492% |
| Blueprint Medicines Corporation | 774.12 Million USD | 16.697% |
| Organovo Holdings, Inc. | 1.39 Million USD | -46160.043% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -25756.656% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -1111736.207% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -662.36% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -308418.324% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -12751.036% |
| Summit Therapeutics Inc. | 106.09 Million USD | -507.796% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -484.339% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -397187.407% |
| Turnstone Biologics Corp. | 3.21 Million USD | -19964.25% |
| Pulmatrix, Inc. | 8.75 Million USD | -7264.836% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -260978.947% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -560.675% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -4556.065% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -459.07% |
| Cytokinetics, Incorporated | 755.77 Million USD | 14.675% |
| Exelixis, Inc. | 189.94 Million USD | -239.503% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2006.438% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -481.337% |
| Evogene Ltd. | 1.13 Million USD | -56566.52% |
| Replimune Group, Inc. | 75.86 Million USD | -749.972% |
| PDS Biotechnology Corporation | 23.85 Million USD | -2603.653% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1168874.894% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -23046.626% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -802689.812% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1319451.872% |
| BioLineRx Ltd. | 11.59 Million USD | -5463.498% |
| Avid Bioservices, Inc. | 207.83 Million USD | -210.279% |
| Insmed Incorporated | 1.2 Billion USD | 46.44% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -30318.16% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1308.833% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -992000.0% |
| MediWound Ltd. | 6.71 Million USD | -9509.075% |
| MiMedx Group, Inc. | 48.09 Million USD | -1240.704% |
| OmniAb, Inc. | 25.56 Million USD | -2422.847% |
| Alector, Inc. | 38.91 Million USD | -1556.984% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -201.429% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -55.379% |
| Mereo BioPharma Group plc | 5.95 Million USD | -10734.425% |
| Zai Lab Limited | 15.15 Million USD | -4156.254% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -34.787% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -39341.284% |
| Aura Biosciences, Inc. | 19.55 Million USD | -3197.362% |
| Immunic, Inc. | 1.33 Million USD | -48240.705% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -2252.234% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1932.223% |
| Veracyte, Inc. | 12.63 Million USD | -5005.819% |
| FibroGen, Inc. | 170.45 Million USD | -278.32% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -7001.255% |
| Allakos Inc. | 41.46 Million USD | -1455.203% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1501.393% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -5859.385% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -426962.914% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -39371.558% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -316148.265% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -15119.849% |
| Precigen, Inc. | 7.09 Million USD | -8986.445% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 61.569% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -8713.243% |
| Incyte Corporation | 38.28 Million USD | -1584.292% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -214344.622% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1393.884% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -5689.774% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -23046.626% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -170.234% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -2376.155% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -184675.072% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -2298.962% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1330.712% |
| Agenus Inc. | 350.24 Million USD | -84.118% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -603192.139% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -45345.032% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1325.557% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1393.815% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1237.09% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -393189.503% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 24.018% |
| UroGen Pharma Ltd. | 100.21 Million USD | -543.488% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -62666.815% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -252.869% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -4543122.488% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -211331.148% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -164405.538% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -9334.748% |
| Chimerix, Inc. | 2.14 Million USD | -29977.659% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -66175.951% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1713.698% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -373360.24% |
| Pluri Inc. | 29.61 Million USD | -2077.715% |
| Cue Biopharma, Inc. | 14.69 Million USD | -4288.329% |
| MeiraGTx Holdings plc | 89.26 Million USD | -622.424% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -3020344.965% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -13122.575% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -943.167% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -519.491% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -9222.9% |
| NLS Pharmaceutics AG | 1.63 Million USD | -39371.558% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1944.075% |
| Nutriband Inc. | 241.28 Thousand USD | -267162.781% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -11695.592% |
| Vor Biopharma Inc. | 35.66 Million USD | -1708.371% |
| Roivant Sciences Ltd. | 499.74 Million USD | -29.038% |
| ProKidney Corp. | 4.41 Million USD | -14512.848% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -52499.103% |
| Daré Bioscience, Inc. | 5.31 Million USD | -12025.751% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 62.935% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -114035.398% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1334.436% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1556.899% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -798.053% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -633.268% |
| Atai Life Sciences N.V. | 16.47 Million USD | -3813.966% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -26210.324% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -95435.556% |
| MediciNova, Inc. | 215.92 Thousand USD | -298550.927% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -25746.293% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -51038.04% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -56417.528% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -246.01% |
| Biomea Fusion, Inc. | 10.29 Million USD | -6163.258% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -1054.451% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -17862.813% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -6939.242% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -4295.508% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -5160.768% |
| bluebird bio, Inc. | 330.32 Million USD | -95.221% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -5056.445% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -39590.986% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 43.127% |
| BioAtla, Inc. | 2.46 Million USD | -26114.024% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -577.942% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -11527.569% |
| DBV Technologies S.A. | 14.38 Million USD | -4384.146% |
| Fortress Biotech, Inc. | 88.59 Million USD | -627.904% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -6445.524% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -3306.037% |
| aTyr Pharma, Inc. | 15.09 Million USD | -4172.044% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2963.783% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -197412.657% |
| Galecto, Inc. | 249 Thousand USD | -258881.928% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -39420.446% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 56.987% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -507.996% |
| Entera Bio Ltd. | 390 Thousand USD | -165250.0% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -59.311% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -10287.645% |
| Xencor, Inc. | 83.43 Million USD | -672.904% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -38125.548% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -13891.43% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -52575.323% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -6757.348% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -393189.503% |
| Portage Biotech Inc. | 47 Thousand USD | -1371953.191% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -51038.04% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -26580.389% |
| OncoCyte Corporation | 2.86 Million USD | -22376.995% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -428228.042% |
| Purple Biotech Ltd. | 351 Thousand USD | -183622.222% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -20313.58% |
| Onconetix, Inc. | 9.88 Million USD | -6423.163% |
| MacroGenics, Inc. | 33.97 Million USD | -1798.281% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -31604.293% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -12227.758% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -4630.177% |
| Aditxt, Inc. | 18.21 Million USD | -3439.716% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -2311.792% |
| Curis, Inc. | 2.79 Million USD | -22980.351% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -30083.964% |
| Adagene Inc. | 22.3 Million USD | -2790.881% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -3754.312% |
| BeiGene, Ltd. | 930.18 Million USD | 30.673% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -206.873% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -79670.337% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -5.548% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -848406.579% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -25673.981% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -686.259% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -213.169% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -13785.982% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 75.961% |
| ADMA Biologics, Inc. | 141.41 Million USD | -355.999% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -964.503% |
| Clene Inc. | 32.16 Million USD | -1905.115% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -25268.411% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -3320.49% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -29278.815% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1172.626% |
| Adicet Bio, Inc. | 20.92 Million USD | -2981.939% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -233.795% |
| Absci Corporation | 15.95 Million USD | -3941.267% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -4113.978% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -3077.771% |
| Surrozen, Inc. | 3.37 Million USD | -18984.492% |
| Generation Bio Co. | 97.89 Million USD | -558.738% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -195907.599% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -2246.243% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -2449.075% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -2527.598% |
| Invivyd, Inc. | 2.16 Million USD | -29685.912% |
| Cingulate Inc. | 3.13 Million USD | -20469.207% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1106.122% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -18300535.974% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -128640.495% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -11533.863% |
| Jaguar Health, Inc. | 35.86 Million USD | -1698.285% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1023495.238% |
| 2seventy bio, Inc. | 256.67 Million USD | -151.24% |
| Clearside Biomedical, Inc. | 43 Million USD | -1399.651% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -106842.786% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1027.288% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -11390.508% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -133899.314% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -2180.932% |
| Innoviva, Inc. | 449.07 Million USD | -43.598% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -3089.401% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -845.134% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -3649.869% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -417.797% |
| Evaxion Biotech A/S | 10.86 Million USD | -5832.696% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -673.321% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -760.888% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -9827.109% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1572741.463% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -2289.274% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -138580.645% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -2251.034% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -6214.158% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -18029.463% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -41370.418% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -51079.762% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -4364.587% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -71077.152% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1146.646% |
| ImmunityBio, Inc. | 883.67 Million USD | 27.025% |
| Korro Bio, Inc. | 33.2 Million USD | -1841.955% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -808.568% |
| Kineta, Inc. | 1.31 Million USD | -48864.692% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -274929.748% |
| BioVie Inc. | 6.11 Million USD | -10451.756% |
| Codexis, Inc. | 22.36 Million USD | -2783.496% |
| Celularity Inc. | 65.41 Million USD | -885.776% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -168272.063% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -287401.115% |
| Kodiak Sciences Inc. | 181.63 Million USD | -255.039% |
| Cibus, Inc. | 24.62 Million USD | -2519.167% |
| Annexon, Inc. | 31.35 Million USD | -1956.658% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -27434.799% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 55.635% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -759.407% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -16422.291% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -3903.443% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -478.406% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1300.693% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1907.799% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -65368.528% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -5528.568% |
| Alkermes plc | 290.73 Million USD | -121.809% |
| Arcellx, Inc. | 97.62 Million USD | -560.553% |
| Moolec Science SA | 2.64 Million USD | -24277.866% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -29907.678% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -10114.874% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -2332.26% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -20688.685% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -26747.002% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -37110.906% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -1009.808% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -2163.717% |
| Geron Corporation | 85.89 Million USD | -650.725% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1316.974% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 89.489% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -559416.373% |
| Notable Labs, Ltd. | 2.04 Million USD | -31372.182% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1806.193% |
| Structure Therapeutics Inc. | 5.45 Million USD | -11725.873% |
| IN8bio, Inc. | 4.89 Million USD | -13079.338% |
| 89bio, Inc. | 27.1 Million USD | -2278.873% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -161116.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1100.687% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -25500.04% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -48096.188% |
| Liquidia Corporation | 3.5 Million USD | -18308.935% |
| Mustang Bio, Inc. | 2.49 Million USD | -25715.252% |
| Immunovant, Inc. | 138 Thousand USD | -467193.478% |
| Vericel Corporation | 88.14 Million USD | -631.612% |
| Quantum-Si incorporated | 15.3 Million USD | -4113.978% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -7294.393% |
| XOMA Corporation | 124.45 Million USD | -418.172% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -235252.19% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -789401.714% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -4757.374% |
| Vaxcyte, Inc. | 29.22 Million USD | -2106.628% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -5814.565% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -317567.488% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -3021.17% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -38911.797% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -51079.762% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -159916.129% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -62386.919% |
| PepGen Inc. | 20.1 Million USD | -3107.645% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -112245.819% |
| United Therapeutics Corporation | 700 Million USD | 7.876% |
| Solid Biosciences Inc. | 26.26 Million USD | -2355.226% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -65368.528% |
| Immuneering Corporation | 4.46 Million USD | -14349.27% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -638380.198% |
| Belite Bio, Inc | 886 Thousand USD | -72683.86% |
| Pharming Group N.V. | 171.54 Million USD | -275.916% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -169.122% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2923.135% |
| uniQure N.V. | 138.4 Million USD | -365.913% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -3731.64% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -654.908% |
| Altimmune, Inc. | 671 Thousand USD | -96005.067% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -4757.374% |
| Peak Bio, Inc. | 10.72 Million USD | -5914.518% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -7001.255% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -36812.707% |
| Benitec Biopharma Inc. | 284 Thousand USD | -226965.141% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -44.894% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -222541.321% |
| Compugen Ltd. | 1.35 Million USD | -47632.42% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -306265.178% |
| argenx SE | 20 Million USD | -3124.325% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1407.892% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -662.657% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -3137.112% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -450.259% |
| PolyPid Ltd. | 11.77 Million USD | -5374.701% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -605.094% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -15323.702% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -110133.333% |
| Instil Bio, Inc. | 86.05 Million USD | -649.372% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2039.778% |
| Immunome, Inc. | 1.65 Million USD | -38982.727% |
| Verona Pharma plc | 51.32 Million USD | -1156.337% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -6495.06% |
| Shattuck Labs, Inc. | 4.2 Million USD | -15246.621% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -178039.503% |
| Design Therapeutics, Inc. | 3.05 Million USD | -21043.115% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -246031.679% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -4432.366% |
| Achilles Therapeutics plc | 4.61 Million USD | -13873.239% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -72.553% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2042.48% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -17338.842% |
| Beam Therapeutics Inc. | 173.17 Million USD | -272.382% |
| Moolec Science SA | 2.64 Million USD | -24277.866% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -135661.053% |
| AEON Biopharma, Inc. | 278 Thousand USD | -231865.827% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -9080.88% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -192397.015% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -750.05% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -955.305% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2034.661% |
| Athira Pharma, Inc. | 1.58 Million USD | -40585.489% |
| HCW Biologics Inc. | 6.45 Million USD | -9895.153% |
| XOMA Corporation | 124.45 Million USD | -418.172% |
| NeurAxis, Inc. | 224.26 Thousand USD | -287452.395% |
| Lumos Pharma, Inc. | 6.58 Million USD | -9692.938% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -6495.06% |
| 180 Life Sciences Corp. | 1.32 Million USD | -48750.856% |
| Nektar Therapeutics | 230.4 Million USD | -179.888% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -3137.112% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -3675.529% |
| Arvinas, Inc. | 3.4 Million USD | -18866.618% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -41370.418% |
| Palisade Bio, Inc. | 369 Thousand USD | -174660.163% |
| Nutriband Inc. | 241.28 Thousand USD | -267162.781% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -39420.446% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -77970.823% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -155289.157% |
| Merus N.V. | 12.16 Million USD | -5202.294% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -402.122% |
| Neurogene Inc. | 16.25 Million USD | -3867.179% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -109.275% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2159.434% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -4568.199% |
| Rezolute, Inc. | 2.22 Million USD | -28843.671% |
| Clene Inc. | 32.16 Million USD | -1905.115% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -368282.718% |
| BeyondSpring Inc. | 3.99 Million USD | -16041.802% |
| Synlogic, Inc. | 17.27 Million USD | -3632.938% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -49505.0% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1842371.429% |
| Peak Bio, Inc. | 10.72 Million USD | -5914.518% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1141.964% |
| Krystal Biotech, Inc. | 8.09 Million USD | -7867.199% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -264.298% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -9037.948% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -472003.46% |
| MannKind Corporation | 382.37 Million USD | -68.646% |
| Ikena Oncology, Inc. | 10.73 Million USD | -5905.448% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -157568.704% |
| Gossamer Bio, Inc. | 212.46 Million USD | -203.517% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -370512.069% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -6939.242% |
| Legend Biotech Corporation | 328.67 Million USD | -96.203% |
| Mural Oncology plc | 15 Million USD | -4196.522% |
| Disc Medicine, Inc. | 2.1 Million USD | -30593.241% |
| Champions Oncology, Inc. | 7.43 Million USD | -8579.206% |
| REGENXBIO Inc. | 89.29 Million USD | -622.214% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -75349.545% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -116515.912% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -11811.064% |
| Vaxart, Inc. | 26.51 Million USD | -2332.168% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -4018.606% |
| Cellectis S.A. | 92.85 Million USD | -594.501% |
| Longeveron Inc. | 2.04 Million USD | -31495.541% |
| Repare Therapeutics Inc. | 3.41 Million USD | -18810.997% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 53.833% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1284.068% |
| Revolution Medicines, Inc. | 87.94 Million USD | -633.268% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -372654.335% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -16213.306% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -203327.445% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -368394.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 20.229% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1134.404% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -4376.531% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -46833.406% |
| Cingulate Inc. | 3.13 Million USD | -20469.207% |
| Passage Bio, Inc. | 26.29 Million USD | -2352.518% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -9575.394% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -157955.147% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -72032.55% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -3036.35% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -26208.983% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -20548.895% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -79414.797% |
| OmniAb, Inc. | 25.56 Million USD | -2422.847% |
| Anew Medical, Inc. | 1.6 Million USD | -40078.505% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -2079.86% |
| Lipocine Inc. | 17.16 Thousand USD | -3756541.035% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -5441.029% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1762.265% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -10816.854% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1027.919% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -317567.488% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -12385.286% |
| Ocugen, Inc. | 6.94 Million USD | -9190.664% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4464.123% |
| Q32 Bio Inc. | 1.31 Million USD | -48827.542% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -95862.054% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1879.328% |
| Equillium, Inc. | 824 Thousand USD | -78160.316% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -7002.82% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -214279.035% |
| Dominari Holdings Inc. | 3.02 Million USD | -21196.731% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -682390.713% |
| vTv Therapeutics Inc. | 529 Thousand USD | -121802.647% |
| Bio-Techne Corporation | 419.53 Million USD | -53.708% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -795.696% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -233.15% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -3718.481% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2733.077% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -10544.85% |
| Nkarta, Inc. | 88.33 Million USD | -629.989% |
| BioCardia, Inc. | 1.31 Million USD | -48939.163% |
| Iterum Therapeutics plc | 19.5 Million USD | -3205.474% |